Arcadia Capital urges Symyx’s Board to reject Accelrys merger

June 1st, 2010
| More
Richard S. Rofe, the managing director of Arcadia Capital Advisors, spoke out against the proposed stock-for-stock merger transaction between Symyx Technologies and Accelrys Inc last week. Since the announcement of the transaction on April 5th, Symyx has reportedly received three all-cash acquisitions offers that valued the company’s shares at $6.00, $6.25, and $6.50. Offers that the Symyx's Board has claimed are "inadequate, from a financial point of view, considering the price offered in comparison to the terms of the proposed Merger with Accelrys and long-term value which the Merger could provide to Symyx stockholders, and Symyx valuation as a stand-alone company."

Arcadia Capital Advisors LLC believes that the competing all-cash proposals were “brazenly” rejected by Symyx’s board and deserve to be more thoroughly reviewed in order to maximize shareholder value. In the hedge fund manager’s merger analysis, it uncovered the following in SEC’s filings:

• Under the terms of the Merger, Symyx shareholders are slated to receive 0.7802 shares of “Accelrys common stock for each Symyx share. As of Tuesday, May 25, 2010, Accelrys common stock closed at $6.73 per share, which implies each share of Symyx, or the "merger-equivalent value," to be worth approximately $5.25 per share at the same contemplated exchange ratio.

• This "merger-equivalent price" of $5.25 per share represents an 11% discount to the market closing price for SMMX on Tuesday, May 25 of $5.91 per share.

• Further, the most recent all-cash offer of $6.50 per share rejected by the Symyx board as "inadequate" actually represents a substantial premium to the "merger-equivalent price" and current Symyx share price. This competitive offer represents a 24% premium to the "merger-equivalent" value of $5.25 per share and a 10% premium to the Symyx stock price of $5.91 at Tuesday's (5/25) market close.

Arcadia Capital reiterated its support for the all-cash offers, as Richard Rofe commented, "As a long-term Symyx shareholder, we would be more comfortable with the certainty of cash now rather than be dependent upon the execution risk, integration risk, market risk, and other uncertainties in the current economic environment related to any expected long-term value of the Symyx-Accelrys combination."
For Detailed Investor Profiles on these Investors, click below:
Arcadia Capital Advisors LLC
Related People: Richard Rofe
Related Entities: Arcadia Capital; Arcadia Opportunity Fund; MD-Sass Macquarie Financial Strategies
Related Article Tags: Shareholder Activists, Corporate Raiders and Proxy Battles

More Recent Headlines

CalSTRS looks to Commodities

Pequot Capital and Art Samberg pay $28 million to settle Insider Trading Charges with SEC

Amid the Financial Turmoil One Economic Indicator is Soaring

Greenlight Capital's David Einhorn shorting ratings agencies

Emerging Markets Specialist Mark Mobius speaks out about shareholder activist responsibilities

The Donor Watch List of Wealthiest College Graduates identifies high potential targets for fundraisers

Hedge Fund Job Report: BlueCrest Capital, Argonaut Capital, Finisterre, Grosvenor, & FrontPoint Partners

Activist Bennett S. LeBow named Chairman of Borders; Gains Approval of Bill Ackman

Matrix Group launches Pan-Asia Long/Short Equity Fund

Gulf Spill Puts US Energy Bill on Slippery Slope